Medindia LOGIN REGISTER
Medindia
Advertisement

Advanced Life Sciences to Present at 2008 UBS Global Life Sciences Conference

Tuesday, September 16, 2008 General News
Advertisement
CHICAGO, Sept. 16 Advanced Life SciencesHoldings, Inc. (Nasdaq: ADLS) today announced that Dr. Michael Flavin,Chairman and CEO will present at the 2008 UBS Global Life Sciences Conferencewhich will be held at the Grand Hyatt New York on Wednesday, September 24 at4:30 p.m. EDT.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

A live webcast of the presentation will be accessible through the InvestorRelations page of the Advanced Life Sciences website athttp://www.advancedlifesciences.com. The presentation will be archived thereas well and available after the event for replay.
Advertisement

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in thediscovery, development and commercialization of novel drugs in the therapeuticareas of infection, cancer and respiratory diseases. The Company's leadcandidate, cethromycin, is a novel once-a-day oral antibiotic in late-stagedevelopment for the treatment of respiratory tract infections includingcommunity acquired pneumonia. For more information, please visit us on the webat http://www.advancedlifesciences.com.

Any statements contained in this presentation that relate to future plans,events or performance are forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995. These forward-lookingstatements are subject to a number of risks and uncertainties that could causeactual results to differ materially from those described in theforward-looking statements. These risks and uncertainties include, amongothers, those relating to technology and product development, marketacceptance, government regulation and regulatory approval processes,intellectual property rights and litigation, dependence on collaborativerelationships, ability to obtain financing, competitive products, industrytrends and other risks identified in Advanced Life Sciences' filings with theSecurities and Exchange Commission. Advanced Life Sciences undertakes noobligation to update or alter these forward-looking statements as a result ofnew information, future events or otherwise.

SOURCE Advanced Life Sciences Holdings, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close